EMA's 'staggered approval' pilot may be delayed
This article was originally published in Scrip
Executive Summary
Plans by the European Medicines Agency to launch a pilot project on introducing staggered approvals of new drugs might be delayed, a spokesperson for the agency has told Scrip's sister publication, Scrip Regulatory Affairs.